Solomiia Kramar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Solomiia Kramar has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Audrey Swiader
National Institute of Health and Medical Research (INSERM) U1297, Paul Sabatier University, Cedex4, 31432 Toulouse, France
1 shared publication - Dimitri Marsal
National Institute of Health and Medical Research (INSERM) U1297, CEDEX 4, 31432 Toulouse, France
1 shared publication - Lesia Savchenko
National Institute of Health and Medical Research (INSERM) U1297, CEDEX 4, 31432 Toulouse, France
1 shared publication - Nathalie Pizzinat
National Institute of Health and Medical Research (INSERM) U1297, CEDEX 4, 31432 Toulouse, France
1 shared publication - Nika Todua
Tbilisi State Medical University
1 shared publication - Oksana Kunduzova
National Institute of Health and Medical Research (INSERM) U1297-University of Toulouse, 31432 Toulouse Cedex 4, France
1 shared publication
Latest Publications
- Open Access
- 5 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 6211
Galanin Coordinates Macrophage-Associated Fibro-Inflammatory Response and Mitochondrial Integrity in Myocardial Infarction Reperfusion Injury
Myocardial infarction activates an intense fibro-inflammatory reaction that is essential for cardiac remodeling and heart failure (HF). Bioactive peptide galanin plays a critical role in regulating cardiovascular homeostasis; however, its specific functional relevance in post-infarction fibro-inflammatory reprogramming remains obscure. Here, we show that galanin coordinates the fibro-inflammatory trajectory and mitochondrial integrity in post-infarction reperfusion injury. Aberrant deposition of collagen was associated with a marked increase in CD68-positive macrophage infiltration in cardiac tissue in mice subjected to myocardial ischemia/reperfusion (I/R) for 14 days compared to sham controls. Furthermore, we found that the myocardial expression level of a specific marker of M2 macrophages, CD206, was significantly down-regulated in I/R-challenged mice. In contrast, galanin treatment started during the reperfusion phase blunted the fibro-inflammatory responses and promoted the expression of CD206 in I/R-remodeled hearts. In addition, we found that the anti-apoptotic and anti-hypertrophic effects of galanin were associated with the preservation of mitochondrial integrity and promotion of mitochondrial biogenesis. These findings depict galanin as a key arbitrator of fibro-inflammatory responses to cardiac I/R injury and offer a promising therapeutic trajectory for the treatment of post-infarct cardiovascular complications.
- 5 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (11) , 6211
Open AccessGalanin Coordinates Macrophage-Associated Fibro-Inflammatory Response and Mitochondrial Integrity in Myocardial Infarction Reperfusion Injury
Myocardial infarction activates an intense fibro-inflammatory reaction that is essential for cardiac remodeling and heart failure (HF). Bioactive peptide galanin plays a critical role in regulating cardiovascular homeostasis; however, its specific functional relevance in post-infarction fibro-inflammatory reprogramming remains obscure. Here, we show that galanin coordinates the fibro-inflammatory trajectory and mitochondrial integrity in post-infarction reperfusion injury. Aberrant deposition of collagen was associated with a marked increase in CD68-positive macrophage infiltration in cardiac tissue in mice subjected to myocardial ischemia/reperfusion (I/R) for 14 days compared to sham controls. Furthermore, we found that the myocardial expression level of a specific marker of M2 macrophages, CD206, was significantly down-regulated in I/R-challenged mice. In contrast, galanin treatment started during the reperfusion phase blunted the fibro-inflammatory responses and promoted the expression of CD206 in I/R-remodeled hearts. In addition, we found that the anti-apoptotic and anti-hypertrophic effects of galanin were associated with the preservation of mitochondrial integrity and promotion of mitochondrial biogenesis. These findings depict galanin as a key arbitrator of fibro-inflammatory responses to cardiac I/R injury and offer a promising therapeutic trajectory for the treatment of post-infarct cardiovascular complications.